Mateusz Brzeziński

Mateusz Brzeziński is a financial and technology journalist at Bez-kabli.pl, covering stocks, artificial intelligence, semiconductors and global market developments. He graduated from the Prague University of Economics and Business in the Czech Republic and previously worked in financial analysis before moving into business journalism. His reporting focuses on the companies, technologies and market trends shaping the global economy.

Performance Shipping stock moves as tanker rates and shelf risk come into focus

Performance Shipping stock moves as tanker rates and shelf risk come into focus

Performance Shipping Inc. shares ticked up on the Nasdaq Wednesday, defying a U.S. market dip. The Greek tanker owner stayed in focus for investors after its latest earnings, recent charters and the cash it can still raise. The stock gained about 1.2% to $1.73 near midday in New York, moving in a range of $1.68 to $1.73. Volume came in at 58,905 shares. The company’s market cap sat around $21.3 million, which puts PSHG in micro-cap territory. That’s the term investors use for firms with market values this size.
June 3, 2026
Booking Holdings Stock Drops as Middle East Risk Weighs on Travel Sector

Booking Holdings Stock Drops as Middle East Risk Weighs on Travel Sector

Booking Holdings Inc. shares were down in late-morning Wednesday, building on Tuesday’s loss as pressure stayed on travel stocks from the wider U.S. equity selloff and new Middle East tensions. Booking traded at $166.54, off 0.4% in recent action, with volume around 1.75 million shares. Expedia Group slipped 0.4% as well. Airbnb lost 0.6%. Online travel stocks lagged as the sector stayed on the defensive.
June 3, 2026
MacroGenics Shares Pop on 2028 Cash Runway Focus

MacroGenics Shares Pop on 2028 Cash Runway Focus

MacroGenics Inc. shares moved higher Wednesday in late-morning trading on the Nasdaq. The stock outperformed other biotech names as investors circled back to the cancer-drug developer, with its cash position and clinical-data timeline getting new attention. The stock last traded at $4.22, putting it up 4.1% on the day after moving between $4.05 and $4.25. Market cap was about $267 million. The SPDR S&P Biotech ETF ticked up 0.6% and the iShares Nasdaq Biotechnology ETF matched that gain. Both ETFs track baskets of biotech stocks.
June 3, 2026
Opendoor Gets Russell Push, Key Test Nears

Opendoor Gets Russell Push, Key Test Nears

Opendoor Technologies Inc shares slipped in premarket trade Wednesday after a strong move up on big volume, driven by its upcoming entry into the Russell 3000 and a renewed effort from CEO Kaz Nejatian to engage retail investors ahead of the annual meeting next week. The stock changed hands near $5.37 premarket, a bit under its $5.41 close on Tuesday. Early session trades ranged from $5.35 to $5.38. U.S. markets were still in premarket trading; regular hours for Nasdaq are 9:30 a.m. to 4:00 p.m. ET.
June 3, 2026
Rectitude Shares Jump in Pre-Market Trading as Little-Known Nasdaq Listed Stock Eyes Construction Angle

Rectitude Shares Jump in Pre-Market Trading as Little-Known Nasdaq Listed Stock Eyes Construction Angle

Rectitude Holdings Ltd stock pointed up ahead of the U.S. open Wednesday, clawing back some of Tuesday’s fall. The small Singapore safety-gear outfit, listed on Nasdaq, traded thinly in premarket. Rectitude shares gained 5.47% to $1.35 in premarket trading, according to Google Finance, compared with Tuesday’s $1.28 finish. The stock dropped 2.29% in regular trade on June 2 and was last valued at roughly $18.6 million with average volume near 45,000 shares.
June 3, 2026
UK & AU Stock Market Today: Live Updates 03.06.2026

UK & AU Stock Market Today: Live Updates 03.06.2026

LIVEMarkets rolling coverageStarted: June 3, 2026, 4:00 AM EDTUpdated: June 4, 2026, 3:55 AM EDT Archer Advances Quantum Machine Learning in Fraud Detection on Quantum Hardware June 4, 2026, 3:55 AM EDT. Archer Materials (ASX: AXE) completed a key phase of its quantum machine learning (QML) project to detect financial fraud using a quantum neural network (QNN). Tested on a public dataset, the QNN matched top classical models, identifying 118 fraudulent transactions with just one false positive on a qubit simulator. The model was also validated on IQM Garnet, a 20-qubit commercial quantum computer via AWS Braket, detecting 18 of
June 3, 2026
Smith-Midland Slips After New Proxy Vote Set

Smith-Midland Slips After New Proxy Vote Set

Smith-Midland Corp shares traded lower Tuesday after the company filed proxy paperwork with a request for shareholders to sign off on a new equity incentive plan at its annual meeting in July. Shares on the Nasdaq finished at $31.21, off $1.22, or 3.76%, at the 4 p.m. Eastern close. By 4:10 p.m. Eastern in light after-hours trading, the stock was quoted at $31.60, according to MarketBeat data.
June 3, 2026
Peoples Financial Stock Moves Up as Investors Eye PFIS

Peoples Financial Stock Moves Up as Investors Eye PFIS

Peoples Financial Services Corp. picked up 1.9% to $59.26 Tuesday. The Pennsylvania lender’s shares hovered near their recent highs, with trading quiet on news. Market cap was around $594 million. Volume came in at 27,520 shares. Regional-bank stocks are seeing buyers return, and Peoples’ latest jump was part of a broader rally. The SPDR S&P Regional Banking ETF, which holds a group of regional bank names, added around 1.8%.
June 3, 2026
Chemomab Drops After Board Changes and CEO Stock Purchase

Chemomab Drops After Board Changes and CEO Stock Purchase

Chemomab Therapeutics’ American depositary shares on Nasdaq were last down 6.5% at $1.74 Tuesday. The move trailed a down biotech sector, after a June 2 regulatory filing showed board and committee changes at the Israeli drug developer. Shares opened at $1.95, hitting a low of $1.74. An ADS is a U.S. receipt for foreign shares. Chemomab is working to push nebokitug, its top antibody, into possible late-stage testing for primary sclerosing cholangitis, or PSC. With the stock thin and cash limited, who's on the board and the status of any partner talks can be nearly as important as what the shares do each day.
June 2, 2026
DiaMedica Shares Down Ahead of Stroke Trial Update

DiaMedica Shares Down Ahead of Stroke Trial Update

DiaMedica Therapeutics Inc. shares fell Tuesday, with the drug developer closing lower as the major indexes gained. The stock was last at $5.77 after hours, off 6 cents from its close. It traded between $6.29 and $5.56 earlier in the session. Volume reached about 152,000 shares. Market cap was roughly $311 million. DiaMedica is heading into a catalyst week as it prepares to present at 3:45 p.m. ET Thursday during the Jefferies Global Healthcare Conference in New York. The event, which runs June 2-4, draws attention from healthcare investors looking for pipeline news and signs of financing.
June 2, 2026
Ondas Stock Climbs After Navy Balloon Deal — Why ONDS Is Back in Focus

Ondas Stock Climbs After Navy Balloon Deal — Why ONDS Is Back in Focus

Ondas Inc. shares were last quoted up about 2% at $13.76 just before Tuesday’s U.S. close, after the defense-technology company said its World View unit had been picked for a U.S. Navy-linked maritime surveillance program. The stock traded between $13.11 and $14.15, with volume above 80 million shares. The move came on a mixed tape. Reuters market data showed the S&P 500 slightly higher and the Nasdaq Composite slightly lower around the same period, keeping the day’s focus on company-specific defense and drone news rather than a broad market lift.
June 2, 2026
Mama’s Creations Investors Track MAMA Stock Before Earnings

Mama’s Creations Investors Track MAMA Stock Before Earnings

Mama’s Creations Inc gained 27 cents to $14.52 in Tuesday’s afternoon session, up around 1.9%. Shares picked up ahead of next week’s earnings report. The stock outperformed the consumer-staples ETF XLP, which slipped about 0.1%. Timing is key. Mama’s Creations will report fiscal Q1 2027 results after the close on June 8, with a 4:30 p.m. Eastern conference call. Investors want to see if gains from new distribution and the Crown 1 deal show up as steady sales or if the boost is limited to just one quarter.
June 2, 2026
Sabre Drops as AI Plays Drive Wall Street; Investors Look to What’s Next

Sabre Drops as AI Plays Drive Wall Street; Investors Look to What’s Next

Sabre Corporation shares slipped in Tuesday’s afternoon session, trailing the broader Wall Street gains. There was little new from the company ahead of the next public investor event, so trading volume was light. Sabre shares last traded at $1.88, off 0.5%. The stock saw a range from $1.815 to $1.90 on Nasdaq. Around 1.66 million shares changed hands. Market value for the company was about $747 million, market data showed.
June 2, 2026
Usio shares tick higher as June vote nears and traders look again at payments stock

Usio shares tick higher as June vote nears and traders look again at payments stock

Usio Inc. shares traded up midday Tuesday on the Nasdaq, reversing a bit of Monday’s losses. Investors are still watching the small payments company after it posted a record first quarter. The stock was last at $1.59, showing a gain of 3 cents, or 1.9%. Volume was 21,028 shares, with the company’s market value around $44.1 million. Usio is thinly traded, so even small buys or sells can have an outsized effect on the price. According to the company’s investor page, Usio shares finished at $1.56 on June 1, down 3.1% for the day. Volume came in at 57,874 shares.
June 2, 2026
Gladstone Land Draws Attention Following Board Decision; Dividend Focus Remains for Farmland REIT

Gladstone Land Draws Attention Following Board Decision; Dividend Focus Remains for Farmland REIT

Gladstone Land Corp. picked up some ground on the Nasdaq Tuesday after naming George “Chip” Stelljes III to its board. The farmland REIT is facing issues with rent collection timing, water expenses and keeping up its dividend. REITs pay out most of their taxable income as dividends. The stock was last seen at $9.255, up 0.7% from where it finished Monday, with around 29,600 shares traded. Farmland Partners, its nearest listed farmland rival, was up 0.6%. The Vanguard Real Estate ETF lost 0.2%. The iShares Russell 2000 ETF, which tracks small-cap stocks, added 0.3%.
June 2, 2026
Viasat stock falls after earnings but Wall Street stays put

Viasat stock falls after earnings but Wall Street stays put

Viasat shares struggled again Monday, dropping 9.63% to $72.86 after Friday’s 7.0% loss, leaving the stock down almost 16% over two days. A new Lockheed Martin subcontract and a price target bump from Needham didn’t stop the bleeding for the satellite communications name. Viasat shares opened lower as investors questioned if the company’s recent space-and-spectrum gains got ahead of what it can deliver on earnings in the near term. The SPDR S&P 500 ETF was quoted about 0.2% above its last close in early trading, so Viasat’s move looked to be tied to the stock rather than the broader market.
June 2, 2026
VivoSim Stock Sits Near 52-Week Low, Biotech Faces Pre-Market Cash Crunch

VivoSim Stock Sits Near 52-Week Low, Biotech Faces Pre-Market Cash Crunch

VivoSim Labs slipped in early pre-market trade Tuesday, last quoted at $1.29, off around 0.8%. The drug-testing microcap is trading just above its 52-week low of $1.22, with a market cap near $3.36 million. That small move stands out since biotech was weak before the bell. The SPDR S&P Biotech ETF was off 2.2% in the latest trading. The iShares Nasdaq Biotechnology ETF lost 1.6%. That drop adds pressure, especially on smaller stocks where trading is light.
June 2, 2026
Cloudastructure Faces Nasdaq Deadline With CSAI Stuck Below 50 Cents

Cloudastructure Faces Nasdaq Deadline With CSAI Stuck Below 50 Cents

Cloudastructure Inc. shares remained under 50 cents before Tuesday’s regular U.S. open after the AI video-surveillance company said it got a Nasdaq noncompliance notice for a delayed quarterly filing. CSAI last traded at $0.478, down around 0.4% from its previous close, putting its market value near $9.4 million, according to market data. Filing delays have shifted from an accounting footnote to a Nasdaq listing-compliance problem. June 2 isn’t a Nasdaq market holiday, so focus turns to the company’s shares and what it does next on the regulatory side.
June 2, 2026
Collective Acquisition Corp. II Stock Sits Below $10 — The SPAC Test Investors Can’t Ignore

Collective Acquisition Corp. II Stock Sits Below $10 — The SPAC Test Investors Can’t Ignore

Collective Acquisition Corp. II units were sitting just below their $10 IPO price before Tuesday’s regular Nasdaq session, a small discount that leaves the newly listed blank-check company trading more like cash than a bet on a named business. The Nasdaq-listed units, ticker CAIIU, last showed $9.975 at 4:30 p.m. EDT on Monday, according to StockLight. Nasdaq regular trading runs from 9:30 a.m. to 4 p.m. Eastern, with premarket trading beginning at 4 a.m., a window that often has thinner liquidity and wider price moves.
June 2, 2026
1 25 26 27 28 29 80